Bromide

Bromide

SCHEMBL2129172

Br.Brc1cccc2c1CCNC2

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CD44 P16070 2/20 0.59
PNMT P11086 4/20 0.51
NISCH Q9Y2I1 1/20 0.50
MAOB P27338 1/20 0.50
ASIC3 Q9UHC3 1/20 0.47
PARP10 Q53GL7 1/20 0.43
PARP11 Q9NR21 1/20 0.43
HTR2C P28335 3/20 0.42
HTR2A P28223 2/20 0.42
HTR2B P41595 2/20 0.42
PRCP P42785 1/20 0.42
GID4 Q8IVV7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1010522 0.98 CD44 (0.61) CD44PNMTNISCHMAOBASIC3
SCHEMBL29586907 0.98 CD44 (0.61) CD44PNMTNISCHMAOBASIC3
Hydrochloric Acid SCHEMBL1922572 0.96 CD44 (0.59) CD44PNMTNISCHMAOBASIC3
Hydrochloric Acid SCHEMBL30955066 0.96 CD44 (0.59) CD44PNMTNISCHMAOBASIC3
SCHEMBL24265584 0.87 CD44 (0.49) CD44PNMTNISCHMAOBASIC3
SCHEMBL24265323 0.84 HTR2C (0.56) CD44PNMTNISCHMAOBASIC3
SCHEMBL3177381 0.82 PNMT (0.67) CD44PNMTNISCHMAOBHTR2C
Hydrochloric Acid SCHEMBL18009924 0.81 PNMT (0.65) CD44PNMTNISCHMAOBHTR2C
SCHEMBL384797 0.79 PNMT (0.44) CD44PNMTNISCHMAOBPARP10
Hydrochloric Acid SCHEMBL2491595 0.78 PNMT (0.43) CD44PNMTNISCHMAOBPARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120101083-A1 S1P1 AGONISTS COMPRISING A BICYCLIC N-CONTAINING RING GLAXO GROUP LIMITED (GB) 2012-04-26 US disclosed
WO-2010146105-A1 S1P1 AGONISTS COMPRISING A BICYCLIC N-CONTAINING RING GLAXO GROUP LIMITED (GB) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101083-A1 S1P1 AGONISTS COMPRISING A BICYCLIC N-CONTAINING RING S1PR1, S1PR2, S1PR3 CD44 4638/4885PNMT 1662/4885NISCH 3633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.